<DOC>
	<DOCNO>NCT00657891</DOCNO>
	<brief_summary>We study Xolair ( omalizumab ) see 's effect allergic blood cell . The blood test do test tube see react differently treatment . The blood cell mixed whatever person allergic .</brief_summary>
	<brief_title>The Effect Xolair ( Omalizumab ) Allergy Blood Cells</brief_title>
	<detailed_description>Must allergic-asthma IgE 30 700 IU/ml .</detailed_description>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>2 year history ragweed allergic rhinitis positive skin prick test ragweed &gt; 5 mm wheal diameter serum IgE &lt; 700 iU/m Use prohibit medication ( e.g . antihistamine past 7 day topical oral corticosteroid past 1 month , betaagonist theophylline 1 week History immunotherapy past 2 year Exposure Omalizumab past 2 year Clinically significant nonallergic perennial rhinitis avoid mediator release due environmental allergen Asthma mild intermittent Women childbearing potential accepted form birth control , well woman breastfeed Known sensitivity study drug Xolair Patients severe medical condition ( ) view investigator prohibit participation study Patients previous history cancer Use investigational agent last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Allergic Asthma</keyword>
	<keyword>Anti IgE</keyword>
	<keyword>Xolair</keyword>
	<keyword>Basophil</keyword>
	<keyword>IL-13</keyword>
	<keyword>IL-4</keyword>
	<keyword>Histamine</keyword>
</DOC>